NDC61570-0019-01: THEOPHYLLINE EXTENDED-RELEASE TA.
THEOPHYLLINE EXTENDED-RELEASE TA. Key specifications include special_features: ANHYDROUS, features_provided: UNIT DOSE, primary_container_type: BOTTLE, therapeutic_equivalent: QUIBRON-T/SR BY BRISTOL-MYERS SQUIBB PHARMACEUTICAL, primary_container_content_quantity: 100.000 TABLETS, active_medicament_medicinal_strength: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-073-1552, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| special_features | ANHYDROUS |
| features_provided | UNIT DOSE |
| primary_container_type | BOTTLE |
| therapeutic_equivalent | QUIBRON-T/SR BY BRISTOL-MYERS SQUIBB PHARMACEUTICAL |
| primary_container_content_quantity | 100.000 TABLETS |
| active_medicament_medicinal_strength | 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT |
| part_name_assigned_by_controlling_agency | THEOPHYLLINE EXTENDED-RELEASE TABLETS 300MG 100S BT |
| NSN | 6505-01-073-1552 |
| THERAPEUTIC EQUIVALENT | THEO-DUR BY KEY PHARM |
| PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
| FEATURES PROVIDED | UNIT DOSE |
| PRIMARY CONTAINER TYPE | STRIP |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | THEOPHYLLINE EXTENDED-RELEASE TABLETS 300MG I.S. 100S PG |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT |